期刊
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
卷 25, 期 1, 页码 1-18出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2013.09.001
关键词
Dietary polyphenols; Antioxidants; Obesity; Molecular mechanism; Cell; Animal; Human
资金
- National Institutes of Health (NIH)/National Center for Complementary and Alternative Medicine (NCCAM) [U01AT006691]
- Laura W. Bush Institute for Women's Health
- Texas Department of Agriculture Food and Fiber Research Program
- National Research Foundation of Korea (NRF) [NRF-2008-220F00013, NRF-2011-0014535]
- Texas Woman's University Research Enhancement Program
- NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [U01AT006691] Funding Source: NIH RePORTER
The prevalence of obesity has steadily increased over the past three decades both in the United States and worldwide. Recent studies have shown the role of dietary polyphenols in the prevention of obesity and obesity-related chronic diseases. Here, we evaluated the impact of commonly consumed polyphenols, including green tea catechins, especially epigallocatechin gallates, resveratrol and curcumin, on obesity and obesity-related inflammation. Cellular studies demonstrated that these dietary polyphenols reduce viability of adipocytes and proliferation of preadipocytes, suppress adipocyte differentiation and triglyceride accumulation, stimulate lipolysis and fatty acid beta-oxidation, and reduce inflammation. Concomitantly, the polyphenols modulate signaling pathways including the adenosine-monophosphate-activated protein kinase, peroxisome proliferator activated receptor gamma, CCAAT/enhancer binding protein alpha, peroxisome proliferator activator receptor gamma activator 1-alpha, sirtuin 1, sterol regulatory element binding protein-1c, uncoupling proteins 1 and 2, and nuclear factor-kappa B that regulate adipogenesis, antioxidant and anti-inflammatory responses. Animal studies strongly suggest that commonly consumed polyphenols described in this review have a pronounced effect on obesity as shown by lower body weight, fat mass and triglycerides through enhancing energy expenditure and fat utilization, and modulating glucose hemostasis. Limited human studies have been conducted in this area and are inconsistent about the antiobesity impact of dietary polyphenols probably due to the various study designs and lengths, variation among subjects (age, gender, ethnicity), chemical forms of the dietary polyphenols used and confounding factors such as other weight-reducing agents. Future randomized controlled trials are warranted to reconcile the discrepancies between preclinical efficacies and inconclusive clinic outcomes of these polyphenols. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据